Weekly Recap: INFY trims FY27 growth to ~1–2% and Optimum adds ~50bps
2 min read
Infosys Limited Sponsored ADR (NSE:INFY) warned of sharply slower FY27 revenue growth amid a European auto ramp‑down, AI‑driven price deflation and weak deal conversion, even as acquisitions, a 6,000‑engineer AI buildout and reskilling aim to shore up growth and margins.
Previous Week Recap
- Infosys Limited Sponsored ADR Guides Cut: Infosys ADR (INFY) is set to cut FY27 constant-currency revenue growth guidance to about 1%–2% (or 1.5%–2.5%), citing a European auto client ramp-down and slower deal conversion; announcement at Q2.
CNBC TV18 - INFY Optimum Healthcare Buy Boosts Growth: INFY's Optimum Healthcare buy should add ~50 bps to Q2FY27 growth; analysts expect acquisitions to contribute ~50 bps to Q2 and ~170 bps to FY27 annual growth.
CNBC TV18 - INFY AI-Driven Price Cuts Pressure Revenue: Infosys (INFY) says AI-driven price cuts and deflation are reducing current revenue; AI-related sales haven’t yet grown enough to offset this shortfall, highlighting near-term revenue pressure.
Moneycontrol - INFY AI Costs Narrow Margin Pressure: AI adoption pressures sector margins; for Infosys (INFY) analysts ...